SEC Form 4 · accession 0001144204-15-071783
Harvard Apparatus Regenerative Technology, Inc. · HRGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Saverio LaFrancesca
Officer — Chief Medical Officer
Period of report
Dec 17, 2015
Accepted (ET)
Dec 18, 2015 · 5:31 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001563665
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 17, 2015 | S | 2,393 | $1.9284 | D | 41,605 | D | |
| Common Stock | Dec 17, 2015 | P | 2,393 | $2.0131 | A | 43,998 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Inadvertent sale not directed by the reporting person of a total of 2,393 shares. The reporting person has made arrangements with the issuer to disgorge short swing profits realized to the issuer, and upon settlement, the reporting person will have discharged in full any obligation under Section 16(b) with respect to the reported transaction.
Remarks
This form has been signed under power of attorney.